Our study provided a multilayered profiling of a PDGFB-driven glioma mouse model using the RCAS-tva delivery system and discovered radiological, histological, and metabolic features that are comparable to human high-grade glioma. This evidence concerns the gene PDGFB and central nervous system cancer.